Susquehanna International Group, LLP Replimune Group, Inc. Transaction History

Susquehanna International Group, LLP

$641 Billion
Q4 2024

A detailed history of Susquehanna International Group, LLP transactions in Replimune Group, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 45,096 shares of REPL stock, worth $515,447. This represents 0.0% of its overall portfolio holdings.

Number of Shares

45,096

Previous 43,380 3.96%

Holding current value

$515,447

Previous $475,000 14.95%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$10.54 - $14.93 $18,086 - $25,619	1,716 Added 3.96%	45,096 $546,000
Q3 2024 Nov 14, 2024	SELL	$8.09 - $11.23 $1.14 Million - $1.58 Million	-140,643 Reduced 76.43%	43,380 $475,000
Q2 2024 Aug 15, 2024	BUY	$5.01 - $9.46 $438,420 - $827,835	87,509 Added 90.67%	184,023 $1.66 Million
Q1 2024 May 07, 2024	BUY	$6.87 - $9.31 $538,841 - $730,220	78,434 Added 433.82%	96,514 $788,000
Q4 2023 Feb 14, 2024	SELL	$6.75 - $16.18 $361,995 - $867,717	-53,629 Reduced 74.79%	18,080 $152,000
Q3 2023 Nov 14, 2023	SELL	$15.96 - $22.18 $962,691 - $1.34 Million	-60,319 Reduced 45.69%	71,709 $1.23 Million
Q2 2023 Aug 11, 2023	BUY	$15.65 - $24.1 $720,056 - $1.11 Million	46,010 Added 53.49%	132,028 $3.07 Million
Q1 2023 May 16, 2023	BUY	$17.48 - $29.09 $1.14 Million - $1.9 Million	65,475 Added 318.72%	86,018 $1.52 Million
Q4 2022 Feb 14, 2023	SELL	$17.09 - $27.91 $368,460 - $601,739	-21,560 Reduced 51.21%	20,543 $558,000
Q3 2022 Nov 14, 2022	BUY	$15.6 - $21.15 $656,806 - $890,478	42,103 New	42,103 $727,000
Q1 2022 May 16, 2022	SELL	$15.24 - $29.75 $196,626 - $383,834	-12,902 Reduced 20.82%	49,072 $833,000
Q4 2021 Feb 14, 2022	BUY	$25.43 - $34.25 $526,579 - $709,214	20,707 Added 50.18%	61,974 $1.68 Million
Q3 2021 Nov 15, 2021	SELL	$28.98 - $39.54 $588,207 - $802,543	-20,297 Reduced 32.97%	41,267 $1.22 Million
Q2 2021 Aug 11, 2021	BUY	$28.5 - $39.37 $356,848 - $492,951	12,521 Added 25.53%	61,564 $2.37 Million
Q1 2021 May 17, 2021	BUY	$30.22 - $45.57 $745,708 - $1.12 Million	24,676 Added 101.27%	49,043 $1.5 Million
Q4 2020 Feb 16, 2021	BUY	$23.5 - $52.65 $572,624 - $1.28 Million	24,367 New	24,367 $930,000

Others Institutions Holding REPL

# of Institutions

161

Shares Held

74.9M

Call Options Held

38.4K

Put Options Held

43.7K

View Full List

About Replimune Group, Inc.

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $564M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

More about REPL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Replimune Group, Inc. Transaction History